The economics will be different (more interesting/tempting) indeed. The point of the anecdote was that vaccine fabrication has been understood for a long time in the context of the scale it's required (again, the case was from the 50s-60s). I don't think any of the "promising vaccines" that are being tested now would fall in the trap of such a production scaling problem. Labs know this will be demanded in the billions.